ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

NCAB Review Of Cancer Control Program Finds It Has Made Substantial Progress But Has Problems

October 13, 1978

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000

Ethics Commission Backs Limited Pilot Program for Compensation Of Injured Research Subjects

January 16, 1981